For the best experience on the Abcam website please upgrade to a modern browser such as
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C or -80°C. Avoid freeze / thaw cycle.
Concentration information loading...
Primary antibody notes
This antibody can be used in a diagnostic panel for immunopathology of malignant melanoma. This antibody is a potential candidate for immunoimaging and immunotherapy of disseminated melanoma.
Light chain type
Abpromise guarantee covers the use of
in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use at an assay dependent concentration. Detects a band of approximately 120 kDa.
Use at an assay dependent concentration.
Malignant melanoma is a malignant neoplasm of melanocytes, arising de novo or from a pre existing benign nevus, which occurs most often in the skin but also may involve other sites.
Membrane; Single-pass membrane protein
Antigen LB39 AA antibody
Antigen SK29 AA antibody
References for Anti-Melanoma antibody [LHM 3] (ab20218)
This product has been referenced in:
et al. Generation and selection of monoclonal antibodies, single-chain Fv and antibody fusion phage specific for human melanoma-associated antigens. Melanoma Res 5:403-11 (1995).
Read more (PubMed: 8589614) »
See 1 Publication
for this product
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"